{
  "id": 10416720,
  "title": "Morepen files first US drug application, eyes generic diabetes market",
  "url": "https://urgent.news/2026/09/28/morepen-files-first-us-drug-application-eyes-generic-diabetes-market",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T09:54:26.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/companies/morepen-files-first-us-drug-application-eyes-generic-diabetes-market/article71519098.ece"
  },
  "original_language": "en",
  "account": null,
  "summary": "Morepen’s first US submission targets a late-stage entry into the global diabetes therapeutics market, leveraging a DPP-4 inhibitor with potential competitive timelines and regulatory milestones",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}